BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18041028)

  • 21. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
    Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
    Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G
    Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.
    Lok SM; Kostyuchenko V; Nybakken GE; Holdaway HA; Battisti AJ; Sukupolvi-Petty S; Sedlak D; Fremont DH; Chipman PR; Roehrig JT; Diamond MS; Kuhn RJ; Rossmann MG
    Nat Struct Mol Biol; 2008 Mar; 15(3):312-7. PubMed ID: 18264114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus.
    Xie X; Zou J; Wang QY; Noble CG; Lescar J; Shi PY
    Virology; 2014 Feb; 450-451():250-7. PubMed ID: 24503088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel binding between pre-membrane protein and vacuolar ATPase is required for efficient dengue virus secretion.
    Duan X; Lu X; Li J; Liu Y
    Biochem Biophys Res Commun; 2008 Aug; 373(2):319-24. PubMed ID: 18573235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the dengue virus envelope glycoprotein expressed in Pichia pastoris.
    Tan BH; Fu JL; Sugrue RJ
    Methods Mol Biol; 2007; 379():163-76. PubMed ID: 17502678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
    Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
    Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection.
    Huang KJ; Yang YC; Lin YS; Huang JH; Liu HS; Yeh TM; Chen SH; Liu CC; Lei HY
    J Immunol; 2006 Mar; 176(5):2825-32. PubMed ID: 16493039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fragment of the envelope protein from dengue-1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice.
    Hermida L; Rodríguez R; Lazo L; Bernardo L; Silva R; Zulueta A; López C; Martín J; Valdés I; del Rosario D; Guillén G; Guzmán MG
    Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):107-14. PubMed ID: 12887334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prokaryotic expression, purification of prM of JEV and preparation of monoclonal antibody].
    Ning BF; Zhu HM; Zhou XJ; Cao Y; Zhou AG
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):65-7. PubMed ID: 18414706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production.
    Limjindaporn T; Wongwiwat W; Noisakran S; Srisawat C; Netsawang J; Puttikhunt C; Kasinrerk W; Avirutnan P; Thiemmeca S; Sriburi R; Sittisombut N; Malasit P; Yenchitsomanus PT
    Biochem Biophys Res Commun; 2009 Feb; 379(2):196-200. PubMed ID: 19105951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a monoclonal antibody specific to a recombinant envelope protein from dengue virus type 4 expressed in Pichia pastoris.
    Pupo-Antúnez M; Rodriguez R; Alvarez M; Amin N; Rodriguez H; Otero A; Guzmán G
    Hybridoma; 2001 Feb; 20(1):35-41. PubMed ID: 11289225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
    Sim AC; Lin W; Tan GK; Sim MS; Chow VT; Alonso S
    Vaccine; 2008 Feb; 26(9):1145-54. PubMed ID: 18243432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
    Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
    Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus.
    Izquierdo A; Bernardo L; Martin J; Santana E; Hermida L; Guillén G; Guzmán MG
    Virus Res; 2008 Dec; 138(1-2):135-8. PubMed ID: 18796319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secreted expression of dengue virus type 2 envelope glycoprotein in eukaryotic cells].
    Zhang S; Gu W; Li C; Miao F; Lu P; Qu J; Wei Y; Zhang QF; Liu QZ; Li JD; Liang MF; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):85-8. PubMed ID: 21863624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and characterization of a monoclonal antibody against prM protein of West Nile virus.
    Guo LP; Huo H; Wang XL; Bu ZG; Hua RH
    Monoclon Antib Immunodiagn Immunother; 2014 Dec; 33(6):438-43. PubMed ID: 25514166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of a dengue anti-complex monoclonal antibody in viral purification].
    Hermida Díaz C; Pupo M; Guzmán Tirado MG; González Garriga M; Marcet Sánchez R
    Rev Cubana Med Trop; 1992; 44(3):171-6. PubMed ID: 9768210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.